|
Sign In to gain access to subscriptions and/or personal tools.
|
Live Tumor-Promoting Effect of β-Naphthoflavone, a Strong CYP 1A1/2 Inducer, and the Relationship between CYP 1A1/2 Induction and Cx32 Decrease in Its Hepatocarcinogenesis in the Rat
Toshiyuki Shoda
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan
Kunitoshi Mitsumori
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan
Hiroshi Onodera
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan
Kazuhiro Toyoda
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan
Chikako Uneyama
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan
Koichi Takada
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan
Masao Hirose
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan
Interrelationships among induction of cytochrome P-450 (CYP) 1A1/2, decrease in connexin 32 (Cx32), and liver tumor-promoting activity by β-naphthoflavone (BNF) in the promotion stage were examined in a 2-stage liver carcinogenesis model. A total of 20 male Fischer 344 rats were initiated with a single intraperitoneal injection of 150 mg/kg of diethylnitrosamine (DEN) or were given the saline vehicle alone. Starting 2 weeks later, they were fed a diet containing 2%, 1%, or 0% BNF for 6 weeks. All animals were subjected to a two-thirds partial hepatectomy at week 3 and were sacrificed at week 8. Absolute and relative liver weights were significantly increased in the DEN+BNF groups as compared to the DEN-alone group. Diffuse hepatocellular hypertrophy with cytoplasmic eosinophilia, sometimes accompanied by development of adenoma-like hepatic foci, was observed in the BNF-treated rats. Remarkable induction of cytochrome CYP 1A1/2 and significant increase in CYP 2E1 were noted in the DEN+BNF groups, and positive immunohistochemical staining for both was observed diffusely. The areas of Cx32-positive spots per hepatocyte in the centrilobular areas of livers of the BNF-treated rats were significantly decreased, but no changes were observed in periportal areas. The numbers and areas of foci positive for glutathione S-transferase placental form were increased in the BNF-treated groups. These results suggest that BNF is a liver tumor promoter that, unlike phenobarbital, does not induce CYP 2B1/2 isozymes, and there seems to be no direct relationship between CYP 1A1/2 induction and Cx32 reduction in BNF hepatocarcinogenesis.
Key Words: Connexin • gap junction • neoplasm • P-450 • phenobarbital • promotion
References
- Andersen ME, Mills JJ, Gargas ML, Kedderis L., Birnbaum LS, Neubert D., Greenlee WF (1993). Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment. Risk Anal 13: 25-36.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brown JP, Dietrich PS (1979). Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test. Activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutat Res 66: 223-240.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Denison MS, Heath-Pagliuso S. (1998). The Ah receptor: A regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull Environ Contam Toxicol 61: 557-568.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- DiGiovanni J. (1990). Inhibition of chemical carcinogenesis. In: Chemical Carcinogenesis and Mutagenesis, Copper CS, Grover PL (eds). Springer-Verlag, Berlin, pp 159-253.
- Diwan BA, Rice JM, Nims RW, Lubet RA, Hu H., Ward JM ( 1988). P450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats. Cancer Res 48: 2492-2497.[Abstract/Free Full Text]
- Diwan BA, Rice JM, Ohshima M., Ward JR, Dove LF ( 1985). Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium and barbituric acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine. J Natl Cancer Inst 74: 509-515.[Web of Science][Medline]
[Order article via Infotrieve]
- Goodman DG, Maronpot RR, Newberne PM, Popp JA, Squire RA (1994). Proliferative and selected other lesions in the liver of rats. In: Guides for Toxicologic Pathology. STP/ARP/Armed Forces Institute of Pathology, Washington, DC, GI-5.
- Isogai M., Shimada N., Kamataki T., Imaoka S., Funae Y. (1993). Changes in the amount of cytochromes P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica 23: 799-807.[Web of Science][Medline]
[Order article via Infotrieve]
- Ito N., Hasegawa R., Imaida K., Hirose M., Shirai T. (1996). Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp Toxicol Pathol 48: 113-119.[Web of Science][Medline]
[Order article via Infotrieve]
- Klaunig JE, Ruch RJ ( 1990). Role of inhibition of intercellular communication in carcinogenesis. Lab Invest 62: 135-146.[Web of Science][Medline]
[Order article via Infotrieve]
- Krutovskikh VA, Mesnil M., Mazzoleni G., Yamasaki H. (1995). Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo: Association with aberrant localization of connexin proteins. Lab Invest 72: 571-577.[Web of Science][Medline]
[Order article via Infotrieve]
- Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.[CrossRef][Medline]
[Order article via Infotrieve]
- Lubet RA, Nims RW, Ward JM, Rice JM, Diwan BA (1989). Induction of cytochrome P450b and its relationship to liver tumor promotion. J Am Coll Toxicol 8: 259-268.[Web of Science]
- McKillop D., Case DE (1991). Mutagenicity, carcinogenicity and toxicity of β-naphthoflavone, a potent inducer of P448. Biochem Pharmacol 41: 1-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Neveu MJ, Babcock KL, Hertzberg EL, Paul DL, Nicholson BJ, Pitot HC (1994). Colocalized alterations in connexin 32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res 54: 3145-3152.[Abstract/Free Full Text]
- Neveu MJ, Hully JR, Paul DL, Pitot HC (1990). Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation. Cancer Commun 2: 21-31.[Web of Science][Medline]
[Order article via Infotrieve]
- Peraino C., Fry Rjm, Staffeldt E., Christopher JP (1975). Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res 35: 2884-2890.[Abstract/Free Full Text]
- Portier C., Tritscher A., Kohn M., Sewall C., Clark G., Edler L., Hoel D., Lucier G. (1993) Ligand/receptor binding for 2,3,7,8-TCDD: Implications for risk assessment. Fundam Appl Toxicol 20: 48-56.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sato K. (1988). Glutathione S-transferase and hepatocarcinogenesis. Jpn J Cancer Res (Gann) 79: 556-572.[Medline]
[Order article via Infotrieve]
- Shinozuka H., Lombardi B., Abanobi SE (1982). A comparative study of the efficacy of four barbiturates as promoters of the development of
 -glutamyltranspeptidase-positive foci in the liver of carcinogen treated rats. Carcinogenesis 3: 1017-1020.[Abstract/Free Full Text] - Shoda T., Mitsumori K., Onodera H., Toyoda K., Uneyama C., Imazawa T., Hirose M. (1999). The relationship between decrease in Cx32 and induction of P450 isozymes in the early phase of clofibrate hepatocarcinogenesis in the rat. Arch Toxicol 73: 373-380.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Shoda T., Onodera H., Takeda M., Uneyama C., Imazawa T., Takegawa K., Yasuhara K., Watanabe T., Hirose M., Mitsumori K. (1999). Liver tumor promoting effects of fenbendazole in rats. Toxicol Pathol 27: 553-562.[Abstract/Free Full Text]
- Takeda A., Kanoh M., Shimazu T., Takeuchi N. (1988). Monoclonal antibodies recognizing different epitopes of the 27-kDa gap junction protein in rat liver. J Biochem 104: 901-907.[Abstract/Free Full Text]
- Yamasaki H., Mesnil M., Omori Y., Mironov N., Krutovskikh V. (1995). Intercellular communication and carcinogenesis. Mutat Res 333: 181-188.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 28, No. 4,
540-547 (2000)
DOI: 10.1177/019262330002800406
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Dewa, J. Nishimura, M. Jin, M. Kawai, Y. Saegusa, T. Harada, M. Shibutani, and K. Mitsumori
Molecular Expression Analysis of {beta}-Naphthoflavone-induced Hepatocellular Tumors in Rats
Toxicol Pathol,
June 1, 2009;
37(4):
446 - 455.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Takizawa, T. Imai, J.-i. Onose, M. Ueda, T. Tamura, K. Mitsumori, K. Izumi, and M. Hirose
Enhancement of Hepatocarcinogenesis by Kojic Acid in Rat Two-Stage Models after Initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine
Toxicol. Sci.,
September 1, 2004;
81(1):
43 - 49.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Hockings, T. Roberts, S. P. Campbell, D. G. Reid, R. W. Greenhill, S. R. Polley, P. Nelson, T. A. Bertram, and K. Kramer
Longitudinal Magnetic Resonance Imaging Quantitation of Rat Liver Regeneration After Partial Hepatectomy
Toxicol Pathol,
August 1, 2002;
30(5):
606 - 610.
[Abstract]
[PDF]
|
|
|
|
|
